NorthRock Partners’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.8K Hold
10,640
﹤0.01% 668
2026
Q1
$18.7K Sell
10,640
-1,068
-9% -$2.32K ﹤0.01% 673
2025
Q4
$27.5K Buy
11,708
+66
+0.6% +$180 ﹤0.01% 614
2025
Q3
$35.6K Buy
11,642
+2
+0% +$6 ﹤0.01% 859
2025
Q2
$32.5K Hold
11,640
﹤0.01% 676
2025
Q1
$41.8K Sell
11,640
-290
-2% -$1.17K ﹤0.01% 696
2024
Q4
$37.6K Buy
11,930
+1,290
+12% +$4.61K ﹤0.01% 671
2024
Q3
$30K Hold
10,640
﹤0.01% 724
2024
Q2
$13.1K Hold
10,640
﹤0.01% 741
2024
Q1
$8.45K Buy
10,640
+138
+1% +$126 ﹤0.01% 747
2023
Q4
$10K Hold
10,502
﹤0.01% 683
2023
Q3
$11.3K Buy
+10,502
New +$12.5K ﹤0.01% 348

Other funds holding CLOV

NorthRock Partners's CLOV Position: Q2 2026 in Review

NorthRock Partners held its Clover Health Investments (CLOV) position steady in Q2 2026 at 10,640 shares worth $55.8K. The position accounts for ﹤0.01% of the portfolio, ranked #668.

NorthRock Partners first reported a position in CLOV in Q3 2023 and has held it in 12 quarters since. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • NorthRock Partners held 10,640 shares of Clover Health Investments worth $55.8K as of Q2 2026.
  • NorthRock Partners left its Clover Health Investments share count unchanged in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of NorthRock Partners's portfolio in Q2 2026, its #668 holding.
  • NorthRock Partners first reported a position in Clover Health Investments in Q3 2023 and has held it in 12 quarters since.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.